跳轉至內容
Merck
全部照片(1)

重要文件

N1165

Sigma-Aldrich

吡莫尼唑

≥98% (HPLC)

同義詞:

NSC 380540, PD 126675, Ro 03-8799;, α-[(2-硝基-1H-咪唑-1-基)甲基]-1-哌啶乙醇, α-((2-硝基咪唑-1-基)甲基)-1-哌啶乙醇;

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C11H18N4O3
CAS號碼:
分子量::
254.29
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

yellow

溶解度

DMSO: >20 mg/mL

儲存溫度

2-8°C

SMILES 字串

OC(CN1CCCCC1)Cn2ccnc2[N+]([O-])=O

InChI

1S/C11H18N4O3/c16-10(8-13-5-2-1-3-6-13)9-14-7-4-12-11(14)15(17)18/h4,7,10,16H,1-3,5-6,8-9H2

InChI 密鑰

WVWOOAYQYLJEFD-UHFFFAOYSA-N

生化/生理作用

吡莫尼唑在2位有一个硝基和一个咪唑环。吡莫尼唑经历还原,在缺氧细胞中被激活。
吡莫尼唑是一种高效且无毒的外源性2-硝基咪唑缺氧标志物。
吡莫尼唑是一种高效且无毒的外源性2-硝基咪唑缺氧标志物。吡莫尼唑与蛋白质、肽和氨基酸中的巯基形成加合物。

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Hypoxia Studies with Pimonidazole in vivo
Aguilera KY and Brekken RA
Bio-protocol, 4(19) (2014)
Glyn Chidlow et al.
Frontiers in neuroscience, 11, 478-478 (2017-09-09)
The vascular hypothesis of glaucoma proposes that retinal ganglion cell axons traversing the optic nerve head (ONH) undergo oxygen and nutrient insufficiency as a result of compromised local blood flow, ultimately leading to their degeneration. To date, evidence for the
Lena-Christin Conradi et al.
Angiogenesis, 20(4), 599-613 (2017-09-07)
Blockade of the glycolytic activator PFKFB3 in cancer cells (using a maximum tolerable dose of 70 mg/kg of the PFKFB3 blocker 3PO) inhibits tumor growth in preclinical models and is currently being tested as a novel anticancer treatment in phase I
Hanneke Stegeman et al.
Head & neck, 36(9), 1288-1295 (2014-03-29)
Hypoxia, metabolism, and growth factor signaling are important prognostic features in most solid tumors. The purpose of this study was to determine whether head and neck squamous cell carcinoma (HNSCC) xenografts show similar biological and molecular characteristics as the primary
Esther A Kleibeuker et al.
Oncotarget, 7(47), 76613-76627 (2016-10-27)
The extent of tumor oxygenation is an important factor contributing to the efficacy of radiation therapy (RTx). Interestingly, several preclinical studies have shown benefit of combining RTx with drugs that inhibit tumor blood vessel growth, i.e. angiostatic therapy. Recent findings

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務